542 related articles for article (PubMed ID: 25384197)
1. MicroRNA Signature and Cardiovascular Dysfunction.
Arunachalam G; Upadhyay R; Ding H; Triggle CR
J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNAs and microRNAs in cardiovascular pathophysiology.
Thum T; Condorelli G
Circ Res; 2015 Feb; 116(4):751-62. PubMed ID: 25677521
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
Hang P; Guo J; Sun C; Du Z
Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA: A new therapeutic strategy for cardiovascular diseases.
Samanta S; Balasubramanian S; Rajasingh S; Patel U; Dhanasekaran A; Dawn B; Rajasingh J
Trends Cardiovasc Med; 2016 Jul; 26(5):407-19. PubMed ID: 27013138
[TBL] [Abstract][Full Text] [Related]
5. Application of microRNAs in diagnosis and treatment of cardiovascular disease.
Wronska A; Kurkowska-Jastrzebska I; Santulli G
Acta Physiol (Oxf); 2015 Jan; 213(1):60-83. PubMed ID: 25362848
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic advances in MicroRNA targeting.
Montgomery RL; van Rooij E
J Cardiovasc Pharmacol; 2011 Jan; 57(1):1-7. PubMed ID: 20729755
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-based therapeutic approaches in the cardiovascular system.
Fiedler J; Gupta SK; Thum T
Cardiovasc Ther; 2012 Feb; 30(1):e9-e15. PubMed ID: 20946325
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs Mediate Beneficial Effects of Exercise in Heart.
Bei Y; Tao L; Cretoiu D; Cretoiu SM; Xiao J
Adv Exp Med Biol; 2017; 1000():261-280. PubMed ID: 29098626
[TBL] [Abstract][Full Text] [Related]
9. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA in cardiovascular biology and disease.
Wojciechowska A; Braniewska A; Kozar-Kamińska K
Adv Clin Exp Med; 2017 Aug; 26(5):865-874. PubMed ID: 29068585
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs: roles in cardiovascular development and disease.
Kalayinia S; Arjmand F; Maleki M; Malakootian M; Singh CP
Cardiovasc Pathol; 2021; 50():107296. PubMed ID: 33022373
[TBL] [Abstract][Full Text] [Related]
12. microRNA therapeutics in cardiovascular disease models.
Dangwal S; Thum T
Annu Rev Pharmacol Toxicol; 2014; 54():185-203. PubMed ID: 24111539
[TBL] [Abstract][Full Text] [Related]
13. miRNAs, polyphenols, and chronic disease.
Bladé C; Baselga-Escudero L; Salvadó MJ; Arola-Arnal A
Mol Nutr Food Res; 2013 Jan; 57(1):58-70. PubMed ID: 23165995
[TBL] [Abstract][Full Text] [Related]
14. microRNAs in cardiovascular disease - clinical application.
Schulte C; Karakas M; Zeller T
Clin Chem Lab Med; 2017 May; 55(5):687-704. PubMed ID: 27914211
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA and Cardiovascular Diseases.
Çakmak HA; Demir M
Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs: role in cardiovascular biology and disease.
Zhang C
Clin Sci (Lond); 2008 Jun; 114(12):699-706. PubMed ID: 18474027
[TBL] [Abstract][Full Text] [Related]
17. Identification of cardiovascular microRNA targetomes.
Fiedler J; Gupta SK; Thum T
J Mol Cell Cardiol; 2011 Nov; 51(5):674-81. PubMed ID: 21888912
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in dysfunctional adipose tissue: cardiovascular implications.
Icli B; Feinberg MW
Cardiovasc Res; 2017 Jul; 113(9):1024-1034. PubMed ID: 28505257
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs and vascular (dys)function.
Hartmann D; Thum T
Vascul Pharmacol; 2011 Oct; 55(4):92-105. PubMed ID: 21802526
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
